Boehringer Ingelheim - researching, developing, manufacturing and marketing of pharmaceuticals

26.01.2012	Boehringer Ingelheim launches ‘Lean-to-Clinic’ program for fast drug product supply
26.01.2012	Boehringer Ingelheim Moves into Phase III for its Head and Neck Cancer Trial Programme for Afatinib* - FOR NON-US MEDIA ONLY
14.12.2011	Boehringer Ingelheim significantly expands its supply center for China
09.12.2011	Boehringer Ingelheim completes patient entry for Phase III trial programme in Hepatitis C - For media outside the U.S.
08.12.2011	Linagliptin demonstrates meaningful improvement in glycaemic control in initial combination therapy with metformin - EX US, UK and UAE Medical Media Only. Under embargo until 08 Dec, 10 am CET

Help